SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 8-K
_____________
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
July 25, 2006
Date of Report (Date of earliest event reported)
____________
ACACIA RESEARCH CORPORATION
(Exact name of Registrant as specified in its Charter)
Delaware (State or Other Jurisdiction of Incorporation) | 000-26068 (Commission File Number) | 95-4405754 (I.R.S. Employer Identification No.) |
| | | |
500 Newport Center Drive,
Newport Beach, California 92660
(Address of Principal Executive Offices)
(949) 480-8300
Registrant's telephone number, including area code
Not Applicable
(Former Name or Former Address, if Changed since Last Report)
ITEM 7.01. REGULATION FD DISCLOSURE
On July 25, 2006, Acacia Research Corporation issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits:
| 99.1 | Press Release dated July 25, 2006, of the Registrant. |
| 99.2 | Letter from Food and Drug Administration, Department of Health & Human Services |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | |
| | ACACIA RESEARCH CORPORATION |
|
|
|
| Date: July 25, 2006 | By: | /s/ Paul R. Ryan |
| | Name: Paul R. Ryan Title: Chairman and Chief Executive Officer |
-2-
Exhibit Index
| Exhibit Number | Description |
| 99.1 | Press Release dated July 25, 2006, of the Registrant. |
| 99.2 | Letter from Food and Drug Administration, Department of Health & Human Services |
